Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
During the last quarter of 2011, OHE team members were involved in discussions and presentations in a range of forums, covering each of OHE’s three areas…
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
Antibacterial drug resistance is a serious and growing worldwide problem that threatens our ability to cure traditionally treatable diseases and to successfully perform numerous surgical procedures…
New: Using Happiness to Value Health
9 November 2011
Paul Dolan is Professor of Behavioural Science in the Department of Social Policy at the London School of Economics and Political Science and also serves as…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
This post reviews OHE’s activities in September 2011 that contributed to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery…
Valuing Health at the End of Life: Public Preferences
13 October 2011
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
Join OHE at ISPOR to discuss multiple criteria decision analysis, value based pricing, risk sharing, post-approval data collection and other key topics in HTA and health…
OHE in the Spotlight: Summer 2011
22 September 2011
This is the first in a series of posts that will review OHE’s contributions to advancing thought and stimulating innovative ideas in its three key research…
HTA and Appropriate Drug Pricing Worldwide
9 September 2011
The August 2011 issue of Health Affairs featured four articles on how and why pricing for pharmaceuticals differs from one country to another. The OHE’s Prof…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key…